期刊文献+

活化的肝星状细胞促进调节性T细胞的表达 被引量:2

Activated hepatic steilate cells promote expression of regulatory T cells
原文传递
导出
摘要 目的越来越多的研究证实,活化的肝星状细胞(hepatic stellate cells,HSCs)具有免疫抑制功能。本研究观察了HSCs对T细胞介导的适应性免疫应答的影响及其与调节性T细胞(regulatory Tcells,Treg)的关系。方法分离培养小鼠HSCs,运用混合淋巴细胞反应(mixed lymphocyte reaction,MLR),体外观察活化的HSCs对T细胞增殖和Treg细胞的影响。结果活化的HSCs能导致树突状细胞(dendritic cells,DCs)介导的适应性免疫应答中T细胞的低反应性:抑制T细胞的增殖,同时诱导Treg细胞的表达。结论活化的HSCs能通过促进Treg细胞表达而诱导适应性免疫应答中T细胞的活化无能,促进免疫耐受。 Objective Accumulating reports have suggested that hepatic stellate ceils (HbCs) exhibit immunosuppressive ability and may he responsible for the occurrence and development of hepatocellular carcinoma (HCC). The mechanisms through which HSCs affect T-cell-induced adaptive im mune responses and the relationship with the regulatory T cells (Treg cells) were studied. Methods We isolated HSCs from wildtype mice to demonstrate the influence of HSCs on T-cell proliferation and explored their effect on Treg cells through mixed leukocyte reactions (MLRs) in vitro. Results We found that activated HSCs could induce T-cell hyporesponsiveness in adaptive immune response by inhibiting the proliferation of T ceils andinereasing the quantity of Treg ceils. Conclusion Activated HSCs may lead to hypoergia of T cells in adaptive immune reaction and up-regulate the expression of Treg cells, thus facilitating immunotolarance.
出处 《中华肝胆外科杂志》 CAS CSCD 北大核心 2012年第4期305-309,共5页 Chinese Journal of Hepatobiliary Surgery
基金 基金项目:重大传染病防治重大科技专项基金(2008zx10002-019)
关键词 肝星状细胞 T细胞 调节性T细胞 Hepatic stellate cell T cell Regulatory T cells
  • 相关文献

参考文献28

  • 1Friedman SL. Hepatic stellate cells:protean,multifunctional,and enigmatic cells of the liver[J].Physiological Reviews,2008.125-172.doi:10.1152/physrev.00013.2007.
  • 2Senoo H,Yoshikawa K,Morii M. Hepatic stellate cell (vitamin A storing cell) and its relative-past,present and future[J].Cell Biology International,2010.1247-1272.doi:10.1042/CBI20100321.
  • 3Wake K. "Sternzellen" in the liver:perisinusoidal cells with special reference to storage of vitamin A[J].American Journal of Anatomy,1971.429-462.doi:10.1002/aja.1001320404.
  • 4Davis BH,Kramer RT,Davidson NO. Retinoic acid modulates rat Ito cell proliferation,collagen,and transforming growth factor beta production[J].Journal of Clinical Investigation,1990.2062-2070.
  • 5Gressner AM,Weiskirchen R,Breitkopf K. Roles of TGFbeta in hepatic fibrosis[J].Frontiers in Bioscience,2002.793-807.
  • 6Friedman SL. Liver fibrosis-from bench to bedside[J].Journal of Hepatology,2003,(Suppl 1):38-53.doi:10.1016/S0168-8278(02)00429-4.
  • 7Friedman SL. Mechanisms of hepatic fibrogenesis[J].Gastroenterology,2008.1655-1669.
  • 8Bomble M,Tacke F,Rink L. Analysis of antigen-presenting functionality of cultured rat hepatic stellate cells and transdifferentiated myofibroblasts[J].Biochemical and Biophysical Research Communications,2010.342-347.doi:10.1016/j.bbrc.2010.04.094.
  • 9Benseler V,McCaughan GW,Schlitt HJ. The liver:a special case in transplantation tolerance[J].Seminars in Liver Disease,2007.194-213.doi:10.1055/s-2007-979471.
  • 10Chen CH,Kuo LM,Chang Y. In vivo immune modulatory activity of hepatic stellate cells in mice[J].Hepatology,2006,(5):1171-1181.doi:10.1002/hep.21379.

二级参考文献49

  • 1彭宝岗,梁力建,何强,匡铭,黄洁夫,吕明德.自体肿瘤疫苗治疗肝癌的实验研究[J].中华肝胆外科杂志,2005,11(8):551-554. 被引量:3
  • 2Greten TF,Manns MP,Korangy F.Immunotherapy of hepatocellular carcinoma.J Hepatol,2006,45:868-878.
  • 3Thomas MB,O'Beirne JP,Furuse J,et al.Systemic therapy for hepatocellular carcinoma:cytotoxic chemotherapy,targeted therapy and immunotherapy.Ann Surg Oncol,2008,15:1008-1014.
  • 4Gao Q,Qiu SJ,Fan J,et al.Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection.J Clin Oncol,2007,25:2586-2593.
  • 5Fu J,Xu D,Liu Z,et al.Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients.Gastroenterology,2007,132:2328-2339.
  • 6Yang XH,Yamagiwa So Ichida T,et al.Increase of CD4^+ CD25^+regulatory T-cells in the liver of patients with hepatocellular carcinoma.J Hepatol,2006,45:254-262.
  • 7Unitt E,Rushbrook SM,Marshall A,et al.Compromised lymphocytes infiltrate hepatocellular carcinoma:the role of Tregulatory cells.Hepatology,2005,41:722-730.
  • 8Zerbini A,Pilli M,Ferrari C,et al.Is there a role for immunotherapy in hepatocellular carcinoma.Dig Liver Dis,2006,38:221-225.
  • 9Wang Y,Chen H,Wu M,et al.Postoperative immunotherapy for patients with hcpatocarcinoma using tumor-infiltrating lymphocytes.Chin Med J(Engl),1997,110:114-117.
  • 10Sakaguchi S,Sakaguchi N,Asano M,et al.Immunologic selftolerance maintained by activated T cells expressing IL-2 receptor alpha-chains(CD25).Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases.J Immunol,1995,155:1151-1164.

共引文献11

同被引文献41

  • 1Soon RK Jr, Yee HF Jr. Stellate cell contraction: role, regulation, and potential therapeutic target [J]. Clin Liver Dis, 2008,12(4):791-803.
  • 2Bai Q, An J, Wu X, et al. HBV promotes the proliferation of hepatic stellate cell via the PDGF-B/PDGFR-β signaling pathway in vitro [J]. Int J of Mol Med, 2012,30(6):1443-1450.
  • 3Kwiecinski M, Elfimova N, Noetel A, et al. Expression of platelet-derived growth factor-Cand insulin-like growth factor I in hepatic stellate cell is inhibited by miR-29 [J]. Lab Invest, 2012,92(7):978-987.
  • 4Reigstad LJ, Varhaug JE, Lillehaug JR. Structural and functional specificities of PDGF-C and PDGF-D, the novel members of the platelet-derived growth factors family [J]. FEBS J, 2005, 272(22):5723-5741.
  • 5Borkham-Kamphorst E, van Roeyen CR, Ostendorf T, et al. Pro-fibrogenic potential of PDGF-D in liver fibrosis [J]. J Hepatol, 2007,46(6):1064-1074.
  • 6Alvarez RH, Kantarjian HM, Cortes JE. Biology of platelet-derived growth factor and its involvement in disease [J]. Mayo Clin Proc, 2006,81(9):1241-1257.
  • 7Cao R, Brakenhielm E, Li X, et al. Angiogenesis stimulated by PDGF-CC, a novel member in the PDGF family, involves activation of PDGFR-alphaalpha and-alphabeta receptors[J]. FASEB J, 2002,16(12):1575-1583.
  • 8Borkham Kamphorst E, Kovalenko E, van Roeyen CR, et al. Platelet-derived growth factor isoform expression in carbon tetrachloride-induced chronic liver injury [J]. Lab Invest, 2008,88(10):1090-1100.
  • 9Thoen LF, Guimares EL, Grunsven LA. Autophagy-a new player in hepatic stellate cell activation [J]. Autophagy, 2012,8(1):126-128.
  • 10Senoo H. Structure and function of hepatic stellate cell[J]. Med Electron Microsc, 2004,37(1):3-15.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部